Intestinal Failure

Gastroenterology·MeSH: Hyperphagia

Prevalence

30.0 / 100K

5 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(3)

Drug	Company
apraglutide	IRONWOOD PHARMACEUTICALS INC (IRWD)
crofelemer powder for	Jaguar Health, Inc. (JAGX)
Intravenous immunoglobulins	ENANTA PHARMACEUTICALS INC (ENTA)

Early Phase 1(1)

Drug	Company
Intralipid, 20% Intravenous Emulsion	ENANTA PHARMACEUTICALS INC (ENTA)

N/A(1)

Drug	Company
Intravenous Amino Acids	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 5 drugs in development for Intestinal Failure across 3 companies.

There are 1 clinical trial targeting Intestinal Failure tracked by BioSniper.

The estimated prevalence of Intestinal Failure is approximately 30.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.